eDruginfo.com - rivastigmine

Drug Updates | New Indications

   Drug Updates
       New Drugs
       New Indications
   Patient Teaching

News Capsules

Drug Warnings

Herbal Spotlight

Quik Tools

Drug Info Links

Drug Info Bookstore

Feedback

Registration

Disclaimer

rivastigmine
Exelon Patch	Pharmaceutical company: Novartis www.novartis.com

NEW INDICATION & DOSAGE
Treatment of mild to moderate dementia of the Alzheimer’s type and treatment of mild to moderate dementia associated with Parkinson’s disease--
Adults: Initially, one patch (4.6 mg/24 hours) once daily. After a minimum of 4 weeks of treatment, dose may be increased to one 9.5 mg patch once daily. Remove old patch before applying a new one.

Home - Guest Registry - Customer Service